Skip to main content
. 2011 Feb 16;96(5):1311–1319. doi: 10.1210/jc.2010-2547

Fig. 4.

Fig. 4.

First- and second-phase insulin levels during the hyperglycemic clamp (A and B), and the disposition index (C), pre- and posttreatment in the drospirenone/EE and the rosiglitazone arms. p, Paired t test; †p, repeated-measures analysis (treatment × time) interaction, confirmed by intent-to-treat analysis. ns, Not significant.